Literature DB >> 29038857

LI-RADS categories: concepts, definitions, and criteria.

Cynthia Santillan1, Victoria Chernyak2, Claude Sirlin3.   

Abstract

The Liver Imaging Reporting and Data System (LI-RADS) was created to provide a standardized way to both assess and communicate the likelihood of benignity or malignancy of observations seen in patients at risk for development of hepatocellular carcinoma (HCC). The LI-RADS categories allow radiologists to convey the full spectrum of concern for malignancy, from definitely benign to definitely HCC. Additional categories are available for non-categorizable observations, observations that are concerning for a non-HCC malignancy, and the presence of tumor in vein. The goal of this paper is to discuss the LI-RADS categories, including criteria for each category, and point out changes to the categories from prior versions of LI-RADS.

Entities:  

Keywords:  CT; Categories; Hepatocellular carcinoma; LI-RADS; Liver; MRI

Mesh:

Substances:

Year:  2018        PMID: 29038857     DOI: 10.1007/s00261-017-1334-x

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  8 in total

Review 1.  LI-RADS 2017: An update.

Authors:  Ania Z Kielar; Victoria Chernyak; Mustafa R Bashir; Richard K Do; Kathryn J Fowler; Donald G Mitchell; Milena Cerny; Khaled M Elsayes; Cynthia Santillan; Aya Kamaya; Yuko Kono; Claude B Sirlin; An Tang
Journal:  J Magn Reson Imaging       Date:  2018-04-06       Impact factor: 4.813

2.  Performance of Gd-EOB-DTPA-enhanced MRI for the diagnosis of LI-RADS 4 category hepatocellular carcinoma nodules with different diameters.

Authors:  Qi Tang; Cong Ma
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

3.  A radiogenomic analysis of hepatocellular carcinoma: association between fractional allelic imbalance rate index and the liver imaging reporting and data system (LI-RADS) categories and features.

Authors:  Alessandro Furlan; Omar Almusa; Robinson K Yu; Hersh Sagreiya; Amir A Borhani; Kyongtae T Bae; J Wallis Marsh
Journal:  Br J Radiol       Date:  2018-04-04       Impact factor: 3.039

4.  Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI.

Authors:  Xinai Liu; Xiaoyan Ni; Yubo Li; Chun Yang; Yi Wang; Chunzheng Ma; Changwu Zhou; Xin Lu
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

Review 5.  Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.

Authors:  Victoria Chernyak; Kathryn J Fowler; Aya Kamaya; Ania Z Kielar; Khaled M Elsayes; Mustafa R Bashir; Yuko Kono; Richard K Do; Donald G Mitchell; Amit G Singal; An Tang; Claude B Sirlin
Journal:  Radiology       Date:  2018-09-25       Impact factor: 11.105

6.  Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib.

Authors:  Shun Kaneko; Kaoru Tsuchiya; Yutaka Yasui; Kento Inada; Sakura Kirino; Koji Yamashita; Leona Osawa; Yuka Hayakawa; Shuhei Sekiguchi; Mayu Higuchi; Kenta Takaura; Chiaki Maeyashiki; Nobuharu Tamaki; Takaya Takeguchi; Yuko Takeguchi; Hiroyuki Nakanishi; Jun Itakura; Yuka Takahashi; Yoshiro Himeno; Masayuki Kurosaki; Namiki Izumi
Journal:  JGH Open       Date:  2020-10-16

7.  Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging.

Authors:  Yidi Chen; Yun Qin; Yuanan Wu; Hong Wei; Yi Wei; Zhen Zhang; Ting Duan; Hanyu Jiang; Bin Song
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

Review 8.  CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017-Can Things Be Put Together?

Authors:  Cosmin Caraiani; Bianca Boca; Vlad Bura; Zeno Sparchez; Yi Dong; Christoph Dietrich
Journal:  Biology (Basel)       Date:  2021-05-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.